NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...
Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
Scientists have used AI to identify two novel subtypes of multiple sclerosis (MS), which could offer new, targeted treatments ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
Two new sub-types of multiple sclerosis (MS) were discovered by researchers from Queen Square Analytics and University ...
Researchers say the more they find out, the more likely 'we will be able to find treatments that can stop disease progression ...
Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...
As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...
Frustrated by past New Year's resolutions, columnist Desiree Lama is setting intentions to help redefine what progress with ...
NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback